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Abstract
Background: Cathepsin B (catB) is a promising target for anti-cancer drug design due to its implication in several
steps of tumorigenesis. catB activity and inhibition are pH-dependent, making it difficult to identify efficient
inhibitor candidates for clinical trials. In addition it is known that heparin binding stabilizes the enzyme in alkaline
conditions. However, the molecular mechanism of stabilization is not well understood, indicating the need for
more detailed structural and dynamic studies in order to clarify the influence of pH and heparin binding on catB
stability.
Results: Our pKa calculations of catB titratable residues revealed distinct protonation states under different pH
conditions for six key residues, of which four lie in the crucial interdomain interface. This implies changes in the
overall charge distribution at the catB surface, as revealed by calculation of the electrostatic potential. We identified
two basic surface regions as possible heparin binding sites, which were confirmed by docking calculations.
Molecular dynamics (MD) of both apo catB and catB-heparin complexes were performed using protonation states
for catB residues corresponding to the relevant acidic or alkaline conditions. The MD of apo catB at pH 5.5 was
very stable, and presented the highest number and occupancy of hydrogen bonds within the inter-domain
interface. In contrast, under alkaline conditions the enzyme’s overall flexibility was increased: interactions between
active site residues were lost, helical content decreased, and domain separation was observed as well as high-
amplitude motions of the occluding loop – a main target of drug design studies. Essential dynamics analysis
revealed that heparin binding modulates large amplitude motions promoting rearrangement of contacts between
catB domains, thus favoring the maintenance of helical content as well as active site stability.
Conclusions: The results of our study contribute to unraveling the molecular events involved in catB inactivation
in alkaline pH, highlighting the fact that protonation changes of few residues can alter the overall dynamics of an
enzyme. Moreover, we propose an allosteric role for heparin in the regulation of catB stability in such a manner
that the restriction of enzyme flexibility would allow the establishment of stronger contacts and thus the
maintenance of overall structure.
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Background
Cathepsin B (EC 3.4.22.1) (catB) is one of the most well-
characterized cysteine proteases, belonging to the clan
CA (papain superfamily). In humans, its physiological
role is implicated in bone resorption, antigen processing
and protein turnover [1]. However, catB also participates
in pathological processes such as cardiovascular distur-
bances [2], parasitic infections [3], Alzheimer’s disease
[4], osteoarthritis [5], tumor invasion and metastasis
development [6,7]. Its main roles in cancer are i) its
activity in directly cleaving extracellular matrix (ECM)
components, ii) its activation of other ECM degrading
proteases, which promotes tumor cell invasion into the
surrounding tissue and bloodstream escape [8], and iii)
stimulating angiogenesis which provides increased nutri-
ents and oxygen supplies to cancer cells [9]. Thus, catB
regulates several crucial steps in tumorigenesis and is a
promising target for anti-cancer drug design [10].
Structurally, catB possesses the regular fold of papain-
like enzymes, enclosing two distinct domains stabilized
by six disulfide bridges, forming a large polar interface
into which project the side chains of a few charged resi-
dues such as E171 and E36 (see Fig. 1). This interdo-
main interface is extremely important to catB overall
activity as it comprises the active site residues (C29,
H199 and N219). Unlike other members of the papain
family, catB exhibits both exo- and endo-proteolytic
activities. Its exo-activity is dependent on the presence
of two adjacent histidine residues (H110 and H111)
located at an insertion region called the “occluding
loop”. These residues provide the necessary positive
charge to anchor the negatively-charged C-terminal car-
boxylate of exo-substrates [11,12]. This region is only
found in catB within its family, and it controls the
access of large substrates to the active site [12]. Site-
directed mutagenesis studies confirmed the role of the
occluding loop since deletion of this entire region
impairs exo- but not endo-proteolytic activity [13].
Additionally, this region confers thermal stability to catB
and resistance against endogenous inhibitors such as
cystatin C [13,14].
Currently the most potent and selective structure-
based designed compounds available are derived from
E-64 targeting the unusual occluding loop present in the
catB 3D-structure [15]. However, enzymatic assays have
shown that these inhibitors are strongly pH dependent
as their optimal binding affinities are considerably
diminished under neutral/alkaline conditions [16]. Since
catB can be found in several cellular compartments with
distinct pH values, these inhibitors are not effective in
vivo. When catB is within the lysosomal or endosomal
vesicles it confronts acidic conditions, in contrast to the
neutral/alkaline environment when it is attached to
membranes (mainly in caveolar microdomains) [17,18]
Figure 1 Localization of differentially protonated residues in catB Cartoon representation of the catB tertiary structure showing differentially
protonated residues as green sticks. Protonation states were assigned to represent acidic (pH 5.5) or alkaline conditions (pH 8) based on pKa
calculations with PROPKA on the catB crystal structure. The L and R domains of the protein are highlighted blue and red, respectively. The
occluding loop (residues 106-124) a structural element found only in catB within its family, is represented in yellow.
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or secreted in the ECM [19]. Although catB is rapidly
inactivated under alkaline pH conditions, it was reported
that membrane-associated forms are resistant to this
process [20]. This peculiarity is believed to occur due to
its interaction with heparan sulfate glycosaminoglycans
(GAGs) on the cell surface [19]. This polysaccharide,
structurally related to heparin, acts on the ECM as a co-
receptor for several molecules such as growth factors
and proteases [21] . Interaction between catB and
heparin-like GAGs was already shown to prevent the
enzyme’s inactivation in high pH [22]. The main
reported outcome was the maintenance of catB helical
content in the presence of heparin at high pH, which
was observed for papain as well [22,23]. Nevertheless, it
has not been possible to precisely define the catB/
heparin interaction sites and the molecular mechanism
responsible for this protective effect.
Structural and molecular modelling studies can give
insight into the molecular events concerning the modifi-
cation of catB activity by pH changes and heparin bind-
ing. Some attempts have already been made towards
designing new catB inhibitors using molecular modeling
techniques [24,25], taking into account dynamical
aspects of binding. However, these studies did not evalu-
ate the influence of pH nor that of heparin binding on
the modulation of the enzyme intrinsic flexibility.
In order to understand the heparin protective effect
over catB structure we performed molecular dynamics
(MD) simulations using an approach in which different
pH conditions were taken into account by considering
different protonation states of titratable groups on the
protein surface. Further, docking analyses resulted in the
identification of two heparin binding sites on catB struc-
ture. The MD calculations confirmed an increase of the
overall catB flexibility and the loss of stability of the apo
catB inter-domain interface in alkaline pH. The destabi-
lization and the increased flexibility, notably in the
occluding loop, were prevented by interaction with
heparin, again in agreement with experimental data. We
observed a role of active site residues in enzyme stabili-
zation and in maintaining the helical content, and we
propose an allosteric mechanism for the stabilizing
effect promoted by GAG interaction. Taken together,
our data provides an improved understanding of the
molecular mechanisms responsible for both pH-induced
inactivation and protection against inactivation by
heparin binding.
Results and discussion
pH changes result in distinct protonation profiles
Prediction of pKa’s for protein ionizable residues is an
important tool for understanding features and catalytic
mechanisms of pH-dependent enzymes [26]. We applied
the PROPKA program to estimate pKa values in the
catB structure and to determine the most probable cor-
responding protonation states of the enzyme under
acidic and alkaline conditions. Two different conditions
were studied: acidic (pH 5.5), and alkaline (pH 8.0),
which allow comparison to available experimental data
[22].
It is known that catalytic residues often present unu-
sual pKa values compared to those of free amino acids
in solution [27]. Accordingly, our results for catB pre-
dicted a pKa of 2.14 for the catalytic C29, in contrast to
8.0 expected in solution. Previous work on the papain
catalytic cysteine (structurally related to C29 in catB)
showed pKa values around 2.5 to 3.5 [28], in accordance
to our estimation for C29.
Comparing the acidic and alkaline conditions we
observed that six key residues are differentially proto-
nated. Table 1 gives the pKa values for these residues
and Fig. 1 shows their positions in the catB structure.
We note that four of these residues belong to the inter-
domain interface (E36, H199, E171 and H110). The pre-
dicted pKa for E171 is 7.71, as carboxyl groups usually
exhibit high pKa values in buried hydrophobic environ-
ments [26]. From our prediction we observed that both
E171 and E36 are likely to be protonated at pH 5.5 but
not in alkaline conditions.
As expected, most of the residues with differing proto-
nation states were histidines, with a pKa in solution of
6.5 and an ionization state that is very susceptible to pH
changes in the physiological range. H110 is a key resi-
due for stabilization of the occluding loop and is also
crucial for the exo-proteolytic activity of catB, since
along with H111 it anchors the carboxyl terminus of
substrates. Interestingly, we observed an pKa of 7.79 for
the catalytic H199, which implies that this residue is
protonated only in acidic conditions. This result is cor-
respondent to the measured pKa of H159 in papain
[28]. In papain, it was previously reported that the
Table 1 Differentially protonated residues in catB and
pKa values
Average values during 40ns MD
Residue predicted crystal pH 5,5 pH 8
C29 2,14 3.7 ± 1.5 7.3 +1.6
E36 5,9 5.4 ± 0.5 3.4 ± 1.2
H97 6,9 7.1 ± 0.2 7.3 ± 0.4
H110 6,6 6.6 ± 0.8 8.1 ± 0.7
E171 7,7 7.4 ± 0.2 6.5 ± 0.4
H190 7,2 7.1 ± 0.2 7.4 ± 0.7
H199 7,8 8.1 ± 2 4.5 ± 1.7
pKa values predicted by PROPKA and the state of ionizable groups under
different pH conditions are indicated. The protonation state of C29 at pH 8
were obtained taking into account deprotonation of H199 as previously
proposed for papain. The protonation states of the catalytic residues (C29 and
H199) are highlighted.
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ionization of the catalytic C25 and H159 residues are
coupled [29]. There the deprotonation of H159 shifts
the pKa of C25 from ~3.3 to 7.6, while the neutraliza-
tion of C25 decreases the pKa of H159 from ~8.5 to 4.3.
Due to the direct relationship between catB and papain
we assigned the protonation states of these residues
according to this proposed mechanism.
The pKa values predicted with PROPKA thus appear
to be sensitive to local microenvironment changes
around the ionizable residues. In order to verify if the
applied protonation profiles accurately represent the dis-
tinct pH conditions simulated, we collected 1000 snap-
shots (one at each 400 ps) from each molecular
dynamics (MD) trajectory in order to perform pKa cal-
culations. Table 1 shows the average pKa values during
the MD simulations. From both pH conditions we
obtained values consistent with the protonation states
predicted from the crystal structure, thus confirming
their validity. In this Table we have also highlighted the
pKa shift in the catalytic residues C29 and H199 as
observed for papain.
Electrostatic potential calculation and docking analyses
reveal two heparin binding sites on catB structure
The electrostatic potential at the catB surface revealed
the influence of the different protonation states for each
of the pH conditions considered. Overall, independent
of the conditions, the catB surface is mostly negative,
presenting one region of positive potential in each
domain (Fig. 2). Under alkaline conditions the overall
surface is qualitatively more negative. The positive sites
are composed of R85, K86, K130, K141 and K144 in the
L-domain, and the catB N-terminus together with K154
and R235 in the R-domain. The protein’s total charge
changes from -11 at pH 8 to -5 at pH 5.5, with six key
residues protonated exclusively under acidic conditions.
Experimental studies have provided knowledge about
the affinity and kinetics of the catB-heparin interaction
[22]. However, the precise binding site(s) has(have) not
been defined. Taking into account that heparin-protein
interactions are mainly driven by charge interactions
due to the high number of sulfate groups found in the
polysaccharide, we visually identified two regions of
positive potential at the catB surface as potential heparin
binding sites. Blind docking calculations confirmed this
prediction, as we found two low energy clusters of dock-
ing poses coincident with these positive regions (Fig. 3A
and B). Almeida and coworkers proposed that heparin
mainly interacts with the occluding loop [22]. From a
structural view this hypothesis appears unlikely due to
the lack of charge and shape complementarity in this
region of the enzyme, and is consistent with the absence
of low-energy clusters for such a mode of binding in the
docking results. Moreover, we carried out another
docking calculation verifying the atomic interactions in
the heparin binding sites more precisely (see Methods).
In the lowest energy complex obtained, heparin interacts
with catB in the R-domain with an energy of -11 Kcal/
mol (Fig. 3B). Although the positive potential at this site
is smaller than that found in the L-domain, in R-domain
site the van der Waals interactions were more favorable
(contributed mainly by L1 at the N-terminus, A3, K154
and R231). We suggest that for a disaccharide the R-
domain site is more important for this interaction; for
longer sugar chains the L-domain could be also impor-
tant for proper heparin accommodation.
catB protonation profile influences protein stability
As flexibility plays a key role in protein biological func-
tions [30], we analyzed the root mean square fluctuation
(RMSF) of catB backbone residues during MD for each
condition simulated. A direct influence of protonation
Figure 2 Electrostatic surface of catB in distinct protonation
states reveals two possible heparin binding sites The
electrostatic surface of catB using protonation states corresponding
to acidic and alkaline pH conditions. Blue, red, and white indicate
positively charged regions, negative areas and neutral regions,
respectively, with the scale indicating ± kbT/ec, where kb is the
Boltzmann constant, T is the temperature and ec is the charge of
one electron. The heparin binding sites correspond to the basic
regions localized in each domain.
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state on the overall enzyme flexibility is clearly seen.
Figure 4A shows that at pH 5.5 the fluctuations were
around 2Å, in contrast to RMSF values up to 5Å
observed at pH 8.0. This behavior was reproducible: we
performed replicate simulations (40 ns each) for each
condition using different initial conditions (see Meth-
ods), with equivalent results (Additional file 1). In addi-
tion, we observed that functional regions such as the
occluding loop and the active site presented the highest
fluctuations at pH 8.0, revealing that alkaline conditions
rapidly affected catB flexibility in regions directly
involved with activity, independent of the starting struc-
ture (Fig. 4A and Additional file 1). Remarkably, this
result shows that changes in protonation of a few resi-
dues can alter both local and non-local properties
(hydrogen bonds, hydration layers and polar contacts).
Local perturbations due to changes in protonation states
have already been observed via MD simulations (e.g.
[31]). However, in our simulations both local and global
flexibility (large-scale protein motions) of catB were
modified as a function of pH, corroborating experimen-
tal findings where catB loses its activity in alkaline pH
in parallel with large structural changes [22].
Heparin binding prevents catB destabilization in alkaline
pH
In MD simulations of the bound enzyme at pH 5.5, the
RMS fluctuation profile was seen to be similar to that of
the apo form (Fig. 4B). Hence, catB is stable under
acidic conditions independent of heparin binding. In
contrast, under alkaline conditions heparin-bound catB
exhibited much smaller backbone fluctuations (2 Å)
than the very flexible apo form in these conditions.
Moreover, we observed similar results when simulations
were started using different initial conformations and
also with heparin docked at the other binding site (L
domain) (Fig. 4B). Functional regions including the
occluding loop and the active site were also stabilized,
showing that heparin binding at the predicted sites pro-
motes a global stabilizing effect.
In Fig. 4C, we show the time-evolution of the number
of distinct clusters of catB backbone conformations
throughout the different MD simulations. Here each
cluster contains conformations within an RMSD of 1 Å
of the cluster center. If during a simulation the system
visits numerous clusters, the RMSD from the starting
structure will be very high, indicating conformational
instability in the simulation. In contrast, if a simulation
visits only a few (correspondingly larger) clusters, it can
be considered as being more conformationally stable.
Indeed, we found few clusters during the simulations of
apo catB and the catB-heparin complex (4 and 2 clus-
ters, respectively) under protonation conditions corre-
sponding to pH 5.5 (Fig. 4C). Furthermore, in acidic
conditions the backbone RMSD distributions, similar to
the RMS fluctuation profiles, did not change signifi-
cantly on binding heparin, presenting deviations in both
cases centered at 2.2 Å. However, in the heparin-bound
simulation in acidic conditions, the RMSD distribution
began to shift towards a conformational state far from
the native structure. (Fig. 4D).
Considering that catB loses stability and activity in
alkaline conditions [22], in the systems simulated under
protonation conditions corresponding to high pH we
expected to observe a higher number of backbone clus-
ters. This expectation was confirmed: we observed 66
clusters in the apo catB simulation (Fig. 4C). In addi-
tion, under these conditions the catB structure does not
stabilize during the simulation, with a continuous
increase of backbone RMSD values throughout the 40
ns production period. A similar profile was observed in
the replica simulation and also when starting with
another conformation (a separate PDB structure, see
Methods), in which we found 47 clusters. The RMS
fluctuations of both replica simulations, plus the simula-
tion performed with the alternative catB structure
(Additional file 1), showed similar results to the apo
enzyme in alkaline conditions (Fig. 4A).
Figure 3 Low-energy catB-heparin complexes Docking
calculations were performed in two steps: firstly a blind docking
calculation with grid spacing of 0.498Å, which revealed the two
positive sites in catB surface as preferential heparin binding sites.
Subsequently a more precise calculation were performed using a
grid (spacing of 0.202 Å) centered in each site. A) Clustering analysis
of 100 low-energy docking results for the first run using a 2 Å RMS
deviation clustering criteria. B) Visualization of the low energy
complexes obtained after the second run for each site. Inset:
Enlarged view of the lowest-energy complex selected for MD
simulations.
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The RMSD distribution plot shows a clear shift divid-
ing into two populations: one around 2 Å and the other
at higher RMSD values. (Fig. 4D). On the other hand, in
the simulation with heparin under alkaline conditions
we observed fewer clusters comparable to acidic condi-
tions (Fig. 4C). This stabilization afforded by heparin
binding is also reflected in the RMSD distribution pre-
senting a narrowed profile centered at small RMSD
values (around 1.7 Å) (Fig. 4D).
Heparin prevents the domain separation observed in
alkaline pH
It was previously postulated that the loss of inter-
domain interface contacts should be a crucial event in
catB inactivation in alkaline pH [32]. Furthermore, the
interface between L and R domains is essential not only
for tertiary structure stabilization but also for the
enzyme activity, as the catalytic triad is formed with
residues from both domains [33]. To address whether
this phenomenon is modulated by heparin, we com-
pared the evolution of the distance between the centers
of mass of the two domains during the simulations. In
acidic conditions, this distance was stable at approxi-
mately 20 Å throughout the entire simulations, and was
not significantly affected by heparin binding (Fig. 5). In
contrast, when the enzyme was simulated under proto-
nation conditions corresponding to alkaline medium, we
observed a remarkable domain separation, with domain
center-of-mass distances of up to 24 Å (Fig. 5). Further,
we observed that this separation increased progressively
Figure 4 Modification of catB flexibility at different pH conditions and upon heparin binding A) Visualization of backbone flexibility
colored according to residue RMS fluctuation values during the 40 ns MD of the apo form of catB in different pH conditions. The black arrows
indicate the catalytic residue C29. B) The same as A but for the complexes catB-heparin. The disaccharide is represented by sticks and its
position corresponds to the binding site (L or R) occupied. C) Time-evolution of RMSD clusters of catB backbone conformations (using a
clustering criteria of 1 Å RMSD). Each system is colored differentially according to the legend D) Backbone RMSD distributions for each
simulation. Colors definitions were applied as in C.
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throughout the simulation, suggesting that total L and R
domain separation could occur at longer time-scales.
This certainly would affect catB catalysis, since the
active site is found inserted into a V-shaped cleft
between the L and R domains. A more detailed analysis
provided by use of the DynDom software [34] revealed
the separation of the L-domain as the principal overall
motion of the enzyme in this condition, thus reinforcing
this conclusion (Fig. 5). This domain motion was
observed in all simulations except those containing
heparin, in which it was not possible to identify large
domain motions with the DynDom program. Remark-
ably, in these last systems, the interdomain distance
remained at approximately 21 Å in alkaline conditions,
comparable to acidic conditions. This shows that
heparin binding governs the inter-domain stability even
under unfavorable alkaline conditions and would pre-
sumably also allow the maintenance of protein activity.
Essential dynamics analysis reveals an allosteric role for
heparin
The results shown above suggest that catB as a whole
and in particular the critical domain interface and
occluding loop are stabilized by heparin binding to a
relatively distant site in the R domain. From basic
thermodynamic principles, preferential binding of ligand
to the native state will generally confer stability to a
macromolecule in what has been described as an allos-
teric mechanism, without necessity for direct interaction
between the ligand binding site and the active site resi-
dues, and has been extensively described in phenomeno-
logical terms [35]. The structural information available
for catB, coupled with macromolecular simulations, pro-
vides a means for investigating details of such a
mechanism directly.
We applied an essential dynamics analysis to examine
the most relevant global macromolecular motions
occurring during the simulations. Such analyses have
been largely applied in the understanding of biological
functions in proteins since they provide an evaluation of
large-scale movements that are often related to domain
motions and conformational changes [36]. We thus
diagonalized the atomic positional covariance matrix to
obtain the eigenvectors and corresponding eigenvalues.
Selecting the first five (largest amplitude) principal com-
ponents, we could recover around 60% of the total
motions for apo catB and around 56% for heparin-
bound catB. Our analysis focused on the systems simu-
lated under alkaline conditions in order to address how
heparin influences catB flexibility and prevents domain
separation as shown above. We point out that certain
analyses involving averaged quantities such as the essen-
tial dynamics and clustering approaches can be best
interpreted for stable systems; the precise results for the
apo catB under alkaline conditions will to some extent
depend on the starting conformation. However, even
under these conditions the overall results obtained were
similar for replicated runs.
We examined the RMS fluctuations of each trajectory
projected onto its five most representative principal
components (PC). When comparing apo and complexed
catB, we observed considerably lower fluctuations in the
latter system for all PC analyzed (Fig. 6A). Further, we
identified that the region around C29 and the occluding
loop presented dramatically higher fluctuations in apo
catB (reaching 3 Å in the two first PC), while in the
complex these regions were shown to be very stable
(deviations around 1Å in all PC). The movements corre-
sponding to the first two components were seen to
comprise relevant motions of both the occluding loop
and active site. Figure 6B shows the directions of indivi-
dual residue movements and also their amplitudes,
which are proportional to the lengths of the arrows in
this representation.
By inspecting other motions corresponding to the first
component (PC1) in the R-domain complexes, we iden-
tified local changes in the binding region. The residues
close to the polysaccharide (L1, A3 K156 and R233)
adopted a new conformation. To verify that these
Figure 5 Heparin prevents domain separation in alkaline pH
Time evolution of the distance between the centers-of-mass of
each catB domain (L and R) during the MD. The domain
nomenclature follows those adopted for papain. The L-domain
corresponds to the amino terminus of catB (with exception of the
first 10 residues) up to Y148 and the last four carboxy-terminal
residues. The R-domain comprises the first 10 residues and the
segment that extends from Y148 until the last four residues. Inset:
Domain definitions of catB (colored red and blue respectively) were
submitted to Domain Select analysis and the main axis of overall
movement for apo catB (pH 8) showing the direction of the domain
separation effect. We selected for this analysis the starting structure
and the average structure of the 40ns MD simulation.
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motions would not lead to loss of binding interaction
between catB and heparin, we measured the distance
between the center of mass of heparin and the positive
site during MD (Additional file 2) and found stable
behavior: heparin remained bound during the entire
simulation. Remarkably, however, this local motion is
coupled to movements far from the heparin binding
site. We observed that the residues 58 to 75 in the L-
domain moved towards the interdomain interface (Fig.
6C). This motion certainly contributes to the stabiliza-
tion of the overall structure, thus helping explain the
results described above (Fig 4 and Fig 5). We did not
find equivalent behavior in the L-domain complexes,
which led us to investigate more deeply the correlated
motions of catB in the apo form and in complex with
heparin.
The analysis of cross correlation coefficients between
pairs of residues is a useful method to identify corre-
lated collective motions [37,38]. The correlation matrix
represents the linear correlation between pairs of C-
alpha atoms as they move about their average positions
during dynamics. Positive correlations are related to
motions occurring in the same direction whereas nega-
tive correlations indicate motion in opposite directions.
We compared the correlation matrix of apo catB and of
the complexes. In the apo form we observed positive
intra-domain correlations but negative inter-domain
correlations (Additional file 3). This pattern is not
observed in the complexes, in which we identified a
more diffuse pattern of correlations regardless of the
binding site occupied. This result shows that heparin
acts mainly as a stabilizing element, and its binding
seems to restrict the anti-correlated collective motions
that would be responsible for domain separation.
Concerning the occluding loop, we observed that the
opening-closing movement is clearly represented by the
two first components in apo catB. On the other hand,
upon heparin binding these motions were not observed,
independent of the binding site occupied. In addition,
the first PC reveals the increasing distance between C29
and the other catalytic residues in apo catB, while in the
complex this motion is absent. Therefore, heparin stabi-
lizes catB motions in its functional regions. These
results are consistent with experimental findings, which,
although they revealed the implications of binding on
the activity of the enzyme, did not provide a structural
view of the phenomenon [22]. Heparin binding, despite
the distance separating it from active site residues, pre-
vents their disorganization as would otherwise be pro-
duced under alkaline conditions. The principal
components obtained from the essential dynamics analy-
sis of our MD simulations suggest that global concerted
movements in the macromolecule leading to domain
separation are suppressed by heparin binding, thus
Figure 6 Allosteric effect of heparin: stabilization of motions in
functional regions of catB A) RMS fluctuations of the trajectories
in alkaline conditions calculated from projection of the MD
trajectories onto the 5 principal components. B) Visualization of the
motions of the active site and occluding loop provided by the first
two principal components. The directions and amplitudes of the
motions are represented by red arrows. C) Concerted motions in
the R-domain complex. The regions with large amplitude
movements are represented in yellow. The representation of
directions and amplitudes is the same as B.
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helping explain an allosteric role for heparin in this bio-
logical system.
Heparin prevents loss of helical content and stabilizes the
occluding loop
Loss of helical content was reported as the main effect
related to alkaline-pH-induced inactivation of catB [22].
In the same study, it was reported that heparin pre-
vented the loss of helical structure, which led to the
postulate that the maintenance of activity in the catB-
heparin complexes is strictly related to this structural
aspect.
In analyzing the time evolution of secondary structural
elements throughout the simulations, we observed stabi-
lity of secondary structure elements in acidic conditions,
independent of heparin binding (data not shown). In
contrast, this same analysis for alkaline conditions
revealed differences in the region of the main alpha
helix (residues 28-45), which is located in the inter-
domain interface. Figure 7A shows the phi-psi distribu-
tion plot for the first residues of the main helix in alka-
line conditions. It is clear that heparin binding
maintained this region in helical form under alkaline
conditions, whereas in the apo simulations the same
region assumed a random coil profile. The fact that
heparin was bound far form this helical region again
emphasizes an allosteric mechanism for this stabiliza-
tion. We also believe that the loss of helical content
seen here on the 40 ns timescale is just a precursor of a
major loss of secondary structure at longer timescales.
It is discussed in the literature that papain-like
enzymes, which possess a similar domain organization,
present structural characteristics that confer some rigid-
ity to the active site region [29]. The most important
element supporting this characteristic is the network of
interactions in the interdomain interface. We verified
the stability of the interaction between catalytic residues
C29-H199 and found that disorganization of the main
alpha helix in apo catB under alkaline conditions is
coupled with the separation of the catalytic residues
(Additional file 5). These events are strongly correlated
with the overall domain motions observed. The binding
of heparin at a substantial distance form the interface
nevertheless stabilizes the interdomain contacts main-
taining the structuring of the active site, and would
explain the results obtained in biochemical assays [22].
The occluding loop controls access to the active site
and also confers the exo-proteolytic activity of the
enzyme. In our simulations, we verified the open-close
mechanism of this region and found that in acidic con-
ditions a stable closed state is maintained regardless of
heparin binding. However, at pH 8.0 the occluding loop
exhibited high flexibility in the absence of heparin (Fig.
7B) as expected after RMSF analysis (Fig 4A).
Nevertheless, under alkaline conditions, when heparin
was bound the occluding loop exhibited a more stable
conformation (Fig. 7B). In this conformation, besides
closing the active site the occluding loop interacts with
the R-domain in a distinct fashion from that observed in
apo catB (Additional file 4). The occurrence of this con-
formation was also independent of the positive site
occupied by heparin since the RMSD between the differ-
ent complexes is around 1.4 Å. On the other hand, the
loop conformations observed in the apo form simula-
tions exhibit higher RMSD values (around 4.5 Å) com-
pared to the complexes.
This result allows a discussion of experimental find-
ings in which it was shown that heparin inhibits the
exo-proteolytic activity of catB [22]. In that study, the
authors proposed a competitive mechanism of inhibition
due to the possible interaction of heparin with H110
and H111, which are the most important residues
involved in accommodation of the negatively-charged C-
terminal substrate carboxylate groups. From our analysis
we conclude that the mechanism of inhibition promoted
by heparin appears to be related also to the induction of
conformational changes in catB, mainly in the occluding
loop region, which adopts a distinct stable conformation
that may impair proper binding of small substrates.
However, we cannot exclude the possibility that large
heparin polymers may also bind to the occluding loop,
thus inhibiting the exo-proteolytic activity of the
enzyme, especially if the concentration of heparin
increases as shown in ref. [22].
A rearrangement of contacts explains heparin-induced
stability at alkaline pH
The catB interface is mainly polar and is stabilized by
ion pairs and hydrogen bonds between buried residues
[12]. Since we see that pH changes induce distinct pro-
tonation profiles mainly at the interface, and also that
heparin binding affects the interface stability, we ana-
lyzed the atomic interactions in this region. In particu-
lar, we verified the permanency of interactions between
interfacial residues in order to see the influence of
heparin binding on their stability (Table 2). We first
checked certain interactions suggested by experimental
studies, such as W30- E171. This interaction was
observed only in the acidic pH simulations (87% apo
catB / 85% catB-hep), and does not occur in alkaline pH
(see Fig. 1 and Table 1) due to deprotonation of the
E171 carboxyl group which interacts with the backbone
of W30. The protonation state of E171 also affects the
interaction between this residue and W80, since the
observed occupancies were higher in acidic pH (88%
apo catB / 87% catB-hep) than in alkaline conditions
(37% apo catB / 68% catB-hep). This interaction was
suggested to be important in the overall maintenance of
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the catB interface [12] and it was significantly stabilized
by heparin binding. Other interactions found to be sta-
bilized by heparin binding are detailed in Table 2.
An important aspect observed through the H-bonding
analysis was the network of contacts between Q23, E36
and S220 (Fig. 8). Concerning the Q23 – S220 contact,
we observed high stability in acidic pH. We identified
two stable H-bonds between these residues in acidic
simulations, while in alkaline conditions only one weak
interaction was found. Further, the occupancy for each
of these contacts was dependent on heparin binding,
since their prevalence increasing from 65% to 82% in
acidic conditions and 6% to 29% at higher pH. It
appears that the lack of one H-bond between Q23 and
S220 in alkaline conditions is compensated by an inter-
action achieved between E36 and S220 only in such
conditions. This occurs due to the distinctive protona-
tion state of E36, which only when ionized (i.e., at pH 8)
is able to interact with S220 through an H-bond.
Remarkably, the occupancy of the E36-S220 interaction
increases from 38% to 72% upon heparin binding. This
result may be explained by the global stabilizing effect
observed (see Essential dynamics analysis) which is cru-
cial in the establishment of this distinct interdomain
contact. The D22-H110 pair is another example of an
interaction that was stabilized by the same mechanism.
We measured the occupancy of this H-bonded state
during the 40ns MD simulation. While in acidic pH
conditions the occupancy of the hydrogen-bonded state
was very high (80% apo catB / 79% catB-heparin), in
alkaline conditions heparin binding significantly
increased the stability of this interaction, which passed
from 6% in apo catB to 67% in the catB-hep complex.
These results are correlated with the distinct loop
conformation observed in the heparin bound complexes
(Additional file 4). In addition, as shown, heparin bind-
ing at the R-domain induces a conformational change
that leads to a more compact structure (Fig 6C).
Further, heparin restricts collective motions involved in
domain separation, which allows the stabilization of a
distinct pattern of interactions formed in the interface
under alkaline conditions.
Conclusions
Heparin-protein interactions are known to regulate sev-
eral biological processes including protease regulation
[39], growth factor activity [40], macromolecular assem-
bly [41] and viral mechanisms [42]. In this paper we
unraveled the molecular mechanism of heparin protec-
tion against pH-induced inactivation of catB. This phe-
nomenon was previously demonstrated through
biochemical assays without a full understanding of the
process because of the lack of structural information
concerning heparin binding. Herein we were able to
mimic the different pH conditions by performing MD
simulations of catB with different protonation states
according to pKa calculations. We confirmed experi-
mental findings showing that under acidic conditions
catB is stable. In contrast, at alkaline pH six residues are
deprotonated, increasing the negative charge of the
interdomain interface. This leads to charge repulsion
and subsequent separation of the L and R domain. In
addition, we observed the effect of the alkaline condi-
tions in terms of destabilization of helical content,
active-site disruption and increases in the flexibility of
the occluding loop. All these events are closely related
to loss of enzyme activity. Heparin binding counteracted
these effects by a long-distance, allosteric mechanism
Figure 7 Heparin binding stabilizes helical content in the
active site and occluding loop A) Phi-Psi distributions for the first
residues of the main alpha helix (residues 28 to 45) in simulations
with protonation corresponding to alkaline conditions. In black :
apo catB; In red catB + heparin (R-domain). We present here the
only the first four residues of the helix (S28, C29, W30 and A31)
since the analysis on the subsequent residues did not shown
observable differences in the distributions. B) Superposition of
structural snapshots collected during MD, highlighting motions of
the occluding loop. The color code from red to blue reflects the
time evolution of the trajectory.
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which appears to be associated with (i) conformational
changes leading to a more compact interface, and (ii)
the restriction of catB flexibility, allowing stabilization
and rearrangement of interdomain contacts under neu-
tral/alkaline conditions. These new findings may be cru-
cial for the design of new catB inhibitors.
Methods
Parameters for cathepsin B and heparin
The three-dimensional atomic coordinates of heparin
were taken from the Protein Data Bank (entry 1HPN)
[43]. From this structure we considered a heparin disac-
charide for our studies. For docking and molecular
dynamics we used the partial charges and force field
parameters for heparin described in ref. [44]. The
human cathepsin B crystal structure (PDB entry: 1HUC)
[12] contains two proteins per asymmetric unit; the pro-
tein consisting of chains A and C was used as the start-
ing structure for docking and MD simulations. The
coordinates of catB complexed with CA-030 (PDB entry:
1CSB) [45] were also used to increase conformational
sampling. We removed the coordinates of the inhibitor
and the enzyme was treated as an apo form.
pKa calculations
To obtain the pKa values for titratable catB residues we
applied the PROPKA web server [26], using the catB
crystal structure as input. This tool uses empirical para-
meters to estimate pKa values of each titratable residue
in its chemical micro-environment, considering the con-
tribution of H-bond formation, charge interactions and
desolvation effects. This method was recently compared
to other pKa predictive tools obtaining excellent results
[46].
Electrostatic surface analysis
With the results of the pKa analysis, we determine the
most probable protonation state for each pH condition
and added hydrogen atoms accordingly. Electrostatic
surface calculations were performed using APBS soft-
ware [47]. This analysis combines the solvent accessible
surface (SAS) calculation with the values of the electro-
static potential for each atom at the surface. This latter
calculation is obtained by the resolution of the linear-
ized Poisson-Boltzmann equation to obtain the surface
charge distribution. Images were generated using PyMol
[48].
Molecular docking
The heparin disaccharide was docked as a ligand with
free rotation for all its torsion angles (sulfate, hydroxyl
groups and glycosidic bonds). Docking calculations were
performed using the Lamarckian Genetic Algorithm
(LGA) implemented in Autodock 3.0 [49], a program
extensively used to predict proteins/polysaccharide bind-
ing modes [50]. We applied a two-step protocol. Initially
we performed blind docking with a grid of probe-atom
interaction energies and the electrostatic potential gen-
erated covering the whole protein with a spacing of
0.498 Å. This step was necessary to obtain the putative
heparin binding sites on catB structure. Subsequently,
we carried out runs taking into consideration only the
regions around the most populated low energy clusters
obtained from the blind docking. In this step we used a
grid spacing of 0.202 Å to evaluate more precisely the
atomic interactions in the binding sites. In all, we per-
formed a total of 100 docking runs using a population
of 200 individuals. The solutions within 2 Å root mean
square deviation of each other were grouped in the
same cluster, which were then ranked according to their
docking energy values. We selected docked structures of
heparin from the lowest energy clusters obtained in our
calculations to assemble two distinct catB-heparin com-
plexes, in which heparin was bound to either one or the
other of the two catB domains. We identify these com-
plexes according to the domain occupied by the sugar
(L or R) and used these structures as starting points for
the energy minimization / MD protocols.
Table 2 Occupancy of hydrogen bonds between interacting interface residues
Percentage of occupancy of hydrogen bonds between interface residues
Interaction Type apo catB (pH 5,5) Apo catB (pH 8,0) catB + hep (pH 5,5) catB + hep (pH 8,0)
W30 – E171 MC-SC 87% — 85% —
W80 – E171 SC-SC 88% 37% 87% 68%
D81 – S150 SC-SC 48% 6% 62% 55%
R41 – P169 SC-MC 70% 42% 83% 91%
Q23 – S220 MC-MC 65% 5% 82% 29%
SC-SC 96% — 90% —
E36-S220 SC/SC — 38% — 72%
D22-H110 SC-SC 80% 6% 79% 67%
Interactions are broken down into main-chain (MC) and sidechain (SC). Domain definitions were used following papain domain organization.
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Molecular dynamics simulation details
Molecular dynamics (MD) simulations, energy minimi-
zation and trajectory analyses were carried out with the
GROMACS 3.1 package [51,52] using the GROMOS96
(G53a6) forcefield [53]. Different pH conditions were
mimicked by changing the protonation states of six key
residues accordingly to pKa calculations and experimen-
tal data as described above. Explicit SPC water
molecules [54] were used in all simulations, in which a
14 Å layer of water molecules were added around the
solute molecules within a cubic water box, using peri-
odic boundary conditions. Counter ions were inserted
for system neutralization. LINCS [55] and SETTLE [56]
were applied to constrain solute and solvent bonds,
respectively. Temperature and pressure were kept at 310
K and 1 atm respectively by the Berendsen approach
[57]. Electrostatic interactions were calculated with the
PME method [58], using non-bonded cutoffs of 1.0 nm
for Coulomb and 1.2 nm for van der Waals. The MD
integration timestep was 2fs.
A three-step energy minimization protocol was used
to avoid artifacts in atomic trajectories due to conver-
sion of potential into kinetic energies: firstly, we applied
the steepest-descent algorithm: i) 5000 steps with solute
heavy atom positions restrained to their initial positions
using a harmonic constant of 1 kJ/mol.nm in each Car-
tesian direction, allowing unrestrained water and hydro-
gen movement; and ii). 5000 steps with all atoms free to
move. Subsequently, the conjugate-gradients algorithm
was applied for further energy minimization until an
energy gradient fell to 42 KJ/mol.nm. A preliminary MD
(1 ns) with heavy atom positions restrained was per-
formed to achieve solvent equilibration and system heat-
ing to 310 K. In this step, initial velocities were
generated for each simulation. A replica simulation was
performed for each system using different initial veloci-
ties. Then we performed a 3 ns unrestrained equilibra-
tion MD for each system followed by a 40ns production
MD.
In the simulations of the heparin-bound complexes,
we verified the heparin-catB interaction stability by mea-
suring the time-evolution of the distances between the
centers of masses of the heparin and catB positive
domains (Additional file 2). This control is important to
guarantee that the effects observed result from the
maintenance of a stable complex during the entire
simulation.
Essential dynamics analysis
We used the last 20 ns of the catB trajectories to obtain
the covariance matrix of C-alpha atomic positions. In
this step we applied the g_covar module of GROMACS
package. Rotation and translation motions were
removed prior to covariance matrix calculation by least-
squares superposition. All analyses were performed with
the g_anaeig module of GROMACS.
Cross correlation analysis
We projected the MD trajectory onto the first principal
component, corresponding to the largest eigenvector, of
the covariance matrix in order to visualize the extreme
structures and the major fluctuations of the correlated
Figure 8 Rearrangement of contacts explains the changes in
flexibility of catB View of the contacts established under the
distinct pH conditions. In apo catB in acidic conditions two stable
interactions are estabilished between Q23 and S220. Due to
deprotonation of E36 in alkaline conditions, the pattern of
interactions is changed and a new interaction is formed (E36 –
S220). However, there is a loss of 1 hydrogen bond between !36
and S220 in this condition. Residues involved in the rearrangement
are represented in stick representation and numbered. The
conformation of D22 is represented since this residue is crucial in
stabilization of the occluding loop.. Domains are colored blue and
red (L and R, respectively). Hydrogen bonds are represented by
dashed lines.
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motions. The correlation matrix, a N×N array whose i-j
entry Corrij summarizes the correlation between the
motions of atoms i and j, is obtained from the reduction
and normalization of the covariance matrix.
Corr
r r r r
r r r r
ij
i i ave j j ave
i i ave j j ave
=
−( ) • −( )
− −
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Domain motions were analyzed with the Domain Select
module of the DynDom software. This program com-
pares two available structures of the same protein and
deduces the rigid-body movement of one domain (the
moving domain) relative to the other domain (the fixed
domain) in the same way as the DynDom program. We
selected the starting structure of each MD and the aver-
age structure of the respective simulation to be
compared.
Clustering analysis
We applied the g_cluster module of GROMACS pack-
age to calculate the RMS clusters of catB backbone con-
formations. Our clustering criteria was 1Å RMSD.
Additional file 1: Similar RMS profiles of deviations are independent
of the starting structure. A) Visualization of backbone flexibility colored
according to residue RMS fluctuation values during the 40 ns MD of the
apo form of catB using the crystal structure with entry:1HUC . B) Same as
A but using the crystal structure of catB entry 1CSB.
Additional file 2: Heparin binding is stable throughout all the
simulations Mean values of the distances between the centers of mass
of each binding site and heparin. Deviations are colored according to
the binding site.
Additional file 3: Cross correlation analysis of catB C-alpha atoms A)
Cross correlation matrix for the apo catB C-alpha atoms. B) Same as A
but for the R-domain complex. C) Same as B but for the L-domain
complex. Correlations close to 1 (colored in red) are related to motions
in the same direction, whereas negative correlations are related to
motions in opposite directions. In the upper left of each matrix are
represented correlations with absolute values higher than 0.5. The
domain organization of catB is represented close to each axis to clarify
the interpretation of domain motions.
Additional file 4: Heparin binding induces a distinct conformation
of the occluding loop Structural alignment of the average structures
obtained from the MD simulations in alkaline conditions. Color
definitions are represented. We represented the occluding loop region in
tubes to highlight the distinct conformation adopted by this structural
element when catB binds heparin.
Additional File 5: Active site behavior during MD of apo catB at pH
5.5 Close-up view of the active-site region .The C-alpha of each catalytic
residue (C29, H199 and N219) is represented as an orange sphere.
Additional File 6: Active site behavior during MD of apo catB at pH
8.0 Close-up view of the active-site region .The C-alpha of each catalytic
residue (C29, H199 and N219) is represented as an orange sphere.
Additional File 7: Active site behavior during MD of catB-heparin
complex at pH 5.5 Close-up view of the active-site region .The C-alpha
of each catalytic residue (C29, H199 and N219) is represented as an
orange sphere.
Additional File 8: Active site behavior during MD of catB-heparin
complex at pH 8.0 Close-up view of the active-site region .The C-alpha
of each catalytic residue (C29, H199 and N219) is represented as an
orange sphere.
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